JACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates

Stock News

Feb 06

JACOBIO-B (01167) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.13% to HK$6.06, with a turnover of HK$14.59 million. Last December, the company announced it had entered a cooperation agreement with AstraZeneca for its self-developed Pan-KRAS inhibitor, JAB-23E73. Additionally, Golecerase was included in the national medical insurance catalog in early 2026, alongside two other domestic KRAS G12C inhibitors. CMB International noted that JAB-23E73 is a core pipeline asset for the company, with risk-adjusted peak sales projected to reach RMB 1.2 billion in China and $1.9 billion overseas. Golecerase, included in the national reimbursement list in January 2026, is expected to see rapid sales growth driven by commercialization efforts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1147384226"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147384226\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147384226?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 13:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147384226","market":"hk","top_or_hot":-1,"title":"JACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates","media":"Stock News","content":"<p>JACOBIO-B (01167) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.13% to HK$6.06, with a turnover of HK$14.59 million. Last December, the company announced it had entered a cooperation agreement with AstraZeneca for its self-developed Pan-KRAS inhibitor, JAB-23E73. Additionally, Golecerase was included in the national medical insurance catalog in early 2026, alongside two other domestic KRAS G12C inhibitors. CMB International noted that JAB-23E73 is a core pipeline asset for the company, with risk-adjusted peak sales projected to reach RMB 1.2 billion in China and $1.9 billion overseas. Golecerase, included in the national reimbursement list in January 2026, is expected to see rapid sales growth driven by commercialization efforts.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-06 13:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JACOBIO-B (01167) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.13% to HK$6.06, with a turnover of HK$14.59 million. Last December, the company announced it had entered a cooperation agreement with AstraZeneca for its self-developed Pan-KRAS inhibitor, JAB-23E73. Additionally, Golecerase was included in the national medical insurance catalog in early 2026, alongside two other domestic KRAS G12C inhibitors. CMB International noted that JAB-23E73 is a core pipeline asset for the company, with risk-adjusted peak sales projected to reach RMB 1.2 billion in China and $1.9 billion overseas. Golecerase, included in the national reimbursement list in January 2026, is expected to see rapid sales growth driven by commercialization efforts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"","article_id":"1147384226","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147384226","pubTimestamp":1770357138,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JACOBIO-B (01167) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.13% to HK$6.06, with a turnover of HK$14.59 million. Last December, the company announced it had...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VXUS":"国际股票ETF-Vanguard","VT":"世界全股市ETF-Vanguard","BK4588":"碎股","BK1161":"生物科技","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","01167":"加科思-B"},"translate_title":"随着JAB-23E73全球开发加速，JACOBIO-B股价在下午交易中飙升超过6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"01167":1,"VT":1},"content_text":"JACOBIO-B (01167) rose more than 6% in afternoon trading. At the time of writing, the stock was up 6.13% to HK$6.06, with a turnover of HK$14.59 million. Last December, the company announced it had entered a cooperation agreement with AstraZeneca for its self-developed Pan-KRAS inhibitor, JAB-23E73. Additionally, Golecerase was included in the national medical insurance catalog in early 2026, alongside two other domestic KRAS G12C inhibitors. CMB International noted that JAB-23E73 is a core pipeline asset for the company, with risk-adjusted peak sales projected to reach RMB 1.2 billion in China and $1.9 billion overseas. Golecerase, included in the national reimbursement list in January 2026, is expected to see rapid sales growth driven by commercialization efforts.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}